• 2-D08 (2’,3’,4’-trihydroxyflavone): Selective Sumoylation In

  2026-07-25

  2-D08 (2’,3’,4’-trihydroxyflavone) is a potent, mechanism-specific inhibitor of protein sumoylation, acting at the UBC9-SUMO transfer step. In vitro, it robustly blocks SUMOylation of topoisomerase I in cancer cell lines without affecting ubiquitination. The compound’s selectivity and solubility profile make it a valuable posttranslational modification inhibitor for research applications.

• URB597 (KDS-4103): Precision FAAH Inhibition in Neuroinflamm

  2026-07-24

  URB597 (KDS-4103) enables rigorous, selective FAAH inhibition for dissecting endocannabinoid signaling in pain and neuroinflammation research. This guide translates recent mechanistic breakthroughs and protocol refinements into actionable workflows, troubleshooting tips, and advanced applications.

• Reliable Application of WY-14643 (Pirinixic Acid) in Cell As

  2026-07-24

  This article provides practical, scenario-driven guidance for using WY-14643 (Pirinixic Acid, SKU A4305) in cell viability, proliferation, and cytotoxicity assays. Leveraging published evidence and product-specific insights, it addresses real laboratory challenges such as solubility, protocol optimization, and data interpretation, ensuring reproducible and sensitive outcomes for biomedical researchers.

• Alpha-Ketoglutarate: Mechanistic Role in Tumor Metabolism

  2026-07-23

  Alpha-ketoglutarate (α-KGA) is a pivotal TCA cycle intermediate and metabolic regulator. Recent evidence links its accumulation to immune modulation and chemotherapy resistance in cholangiocarcinoma. This article provides a mechanistic overview, evidence benchmarks, and workflow guidance for α-KGA use in metabolic reprogramming research.

• Phenothiazines Boost Macrophage Antibacterial Activity via R

  2026-07-23

  This study demonstrates that phenothiazines, a class of dopamine receptor antagonists, markedly enhance macrophage antibacterial capacity by inducing reactive oxygen species (ROS) and autophagy. The findings highlight a host-directed therapeutic strategy for combating intracellular bacterial infections, suggesting translational potential for phenothiazine compounds in infectious disease research.

• Neuroligin 1 Deficiency Drives Repetitive Behaviors via PKC

  2026-07-22

  This study reveals that loss of Neuroligin 1 in striatal D2-MSNs leads to autistic-like repetitive behaviors through hyperactivation of PKC signaling. These findings clarify the cellular and molecular mechanisms underlying restricted behaviors in autism, highlighting PKC as a potential intervention target.

• n-Dodecyl-β-D-maltoside: Precision Tools for Translational M

  2026-07-22

  Explore how n-Dodecyl-β-D-maltoside (DDM) is redefining the boundaries of membrane protein research and translational drug discovery. This article bridges mechanistic insight with strategic guidance, spotlighting M. tuberculosis WecA as a case study, and charts the competitive and translational landscape for innovative membrane protein workflows.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody: Workflow Solutions

  2026-07-21

  This article provides a scenario-driven guide for biomedical researchers using HRP Rabbit Anti-Goat IgG (H+L) Antibody (SKU K1224) to address key challenges in immunodetection, particularly in cell viability and pulmonary fibrosis models involving micro- and nanoplastics. By integrating validated best practices, protocol parameters, and vendor-selection insights, it offers practical, evidence-based recommendations for robust, reproducible data.

• O-propargyl-puromycin (OPP): Precision Tools for Protein Syn

  2026-07-21

  Discover how O-propargyl-puromycin (OPP) enables precise, quantitative protein synthesis measurement in live cells. This article provides advanced protocol guidance and a critical analysis of recent research, offering unique insights for proteomics and immunology applications.

• hCG-Regulated CXCL10 Suppression via H3K27me3 in Decidua

  2026-07-20

  This study reveals that human chorionic gonadotropin (hCG) suppresses the chemokine CXCL10 in human decidual stromal cells through the induction of H3K27me3 histone methylation, mediated by EZH2 of the PRC2 complex. These findings highlight a crucial epigenetic mechanism for immune cell recruitment at the maternal-fetal interface and offer new perspectives for epigenetic regulation research.

• Advances in Antifungal Therapy: Oteseconazole and Candida au

  2026-07-20

  This systematic review highlights the urgent need for new antifungal agents to address multidrug-resistant Candida auris infections and evaluates the in vitro and in vivo activity of agents in the current antifungal pipeline. Tetrazole CYP51 inhibitors such as Oteseconazole (VT-1161) emerge as promising candidates, demonstrating improved selectivity, potency, and potential to overcome resistance mechanisms.

• Molidustat (BAY85-3934): Optimizing HIF Stabilization for Re

  2026-07-19

  Molidustat (BAY85-3934) offers precise, reliable hypoxia-inducible factor stabilization for robust erythropoietin research and chronic kidney disease anemia models. This guide details actionable workflows, key reference insights, and troubleshooting strategies to maximize the translational power of APExBIO’s Molidustat.

• Carbenoxolone Disodium: Technical Use Guide for 11β-HSD Inhi

  2026-07-18

  Carbenoxolone disodium is a high-purity 11β-hydroxysteroid dehydrogenase inhibitor designed for mechanistic studies of glucocorticoid regulation and gap junction communication in tissue- and cell-based research. It is not intended for in vivo efficacy studies or for experiments demanding rigorous off-target specificity.

• HMGCS2 Downregulation Drives AECII Lipid Alterations in Pulm

  2026-07-17

  Yang et al. (2024) reveal that loss of HMGCS2 in alveolar epithelial cells disrupts lipid metabolism, causing lysophosphatidylcholine accumulation that activates fibroblasts and accelerates pulmonary fibrosis. This mechanistic insight clarifies the cellular origin of pathogenic lipids and suggests new intervention points for fibrosis research.

• Optimizing Cancer Assays with MK-1775 (Wee1 Kinase Inhibitor

  2026-07-17

  This article explores real-world laboratory scenarios in which MK-1775 (Wee1 kinase inhibitor, SKU A5755) enables precise, reproducible cell cycle checkpoint abrogation and sensitization of p53-deficient tumor cells. By grounding best practices in published evidence and practical parameters, the guide empowers researchers to leverage reliable performance data and validated protocols for advanced in vitro cancer assays.

449 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page